Sionna Therapeutics Files Proxy Statement for June Meeting
Ticker: SION · Form: DEF 14A · Filed: Apr 29, 2025 · CIK: 2036042
Sentiment: neutral
Topics: proxy-statement, governance, annual-meeting
TL;DR
Sionna Proxy filed. Vote on directors & auditors for June 12 meeting.
AI Summary
Sionna Therapeutics, Inc. filed its definitive proxy statement on April 29, 2025, for its annual meeting on June 12, 2025. The company, incorporated in Delaware and headquartered in Waltham, MA, is in the pharmaceutical preparations industry. This filing outlines the agenda and proposals for the shareholder meeting, which typically includes the election of directors and ratification of auditors.
Why It Matters
This filing provides shareholders with crucial information regarding the company's governance and upcoming decisions, allowing them to make informed voting choices.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not contain new material financial or operational information.
Key Numbers
- 001-42504 — SEC File Number (Identifies the company's filings with the SEC.)
Key Players & Entities
- Sionna Therapeutics, Inc. (company) — Registrant
- 20250429 (date) — Filing Date
- 20250612 (date) — Meeting Date
- Waltham, MA (location) — Company Headquarters
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, also known as a definitive proxy statement, is used by companies to solicit shareholder votes on important matters such as the election of directors, executive compensation, and ratification of auditors.
When is the shareholder meeting for Sionna Therapeutics?
The shareholder meeting for Sionna Therapeutics is scheduled for June 12, 2025.
What is the filing date of this proxy statement?
This definitive proxy statement was filed on April 29, 2025.
Where is Sionna Therapeutics, Inc. headquartered?
Sionna Therapeutics, Inc. is headquartered at 21 Hickory Drive, Suite 500, Waltham, MA 02451.
What is the Standard Industrial Classification (SIC) code for Sionna Therapeutics?
The SIC code for Sionna Therapeutics is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 29, 2025 regarding Sionna Therapeutics, Inc. (SION).